Anna B. Berry, MD

Anna B. Berry, MD
Scientific Director of Personalized Medicine
Swedish Cancer Institute

Ms. Berry is Scientific Director of Personalized Medicine for the Swedish Cancer Institute and Medical Director of Molecular Pathology at CellNetix. Prior to joining CellNetix, she was Associate Professor of Pathology at University of California San Francisco. She is board certified in Molecular Genetic Pathology and Cytopathology. She received her fellowship in Molecular Genetic Pathology from the Medical College of Virginia and her fellowship in Cytopathology from the National Cancer Institute in Bethesda, Maryland.


Launching a Precision Medicine Program: Real-World Solutions to Practical Challenges
Breakout Session
11:20 AM - 12:10 PM